Brief: Oncozenge Receives Investment Capital From Yangtian Bio-Pharmaceutical

Oncozenge AB

12/02/2026 09:36

Feb 12 (Reuters) - Oncozenge AB ONCOZ.ST:

ONCOZENGE RECEIVES INVESTMENT CAPITAL FROM YANGTIAN BIO-PHARMACEUTICAL

INVESTMENT AMOUNTS TO SEK 9.1 MILLION

Source text: ID:nMFN7ZJmjq

Further company coverage: ONCOZ.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))